Astria Therapeutics (ATXS) News Today → “The Stock Market’s Bull Run is Far from Over” -Barrons (From Vertical Research Advisory) (Ad) Free ATXS Stock Alerts $14.08 +0.47 (+3.45%) (As of 03/28/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAstria Therapeutics (NASDAQ:ATXS) Sees Unusually-High Trading Volumemarketbeat.com - March 27 at 12:44 PMAstria Therapeutics (NASDAQ:ATXS) Reaches New 52-Week High Following Analyst Upgradeamericanbankingnews.com - March 27 at 5:10 AMAstria Therapeutics (NASDAQ:ATXS) Receives Outperform Rating from Wedbushamericanbankingnews.com - March 27 at 3:30 AMAstria Therapeutics (NASDAQ:ATXS) Shares Gap Up Following Analyst Upgradeamericanbankingnews.com - March 27 at 2:46 AMJefferies Financial Group Raises Astria Therapeutics (NASDAQ:ATXS) Price Target to $27.00americanbankingnews.com - March 27 at 1:34 AMBuy Recommendation for Astria Therapeutics Backed by Promising ALPHA-STAR Trial Resultsmarkets.businessinsider.com - March 26 at 2:19 PMWedbush Reiterates "Outperform" Rating for Astria Therapeutics (NASDAQ:ATXS)marketbeat.com - March 26 at 9:34 AMAstria Therapeutics (NASDAQ:ATXS) Price Target Increased to $27.00 by Analysts at Jefferies Financial Groupmarketbeat.com - March 26 at 8:48 AMAstria Therapeutics (NASDAQ:ATXS) Earns "Buy" Rating from HC Wainwrightamericanbankingnews.com - March 26 at 4:20 AMAnalysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Astria Therapeutics (ATXS)markets.businessinsider.com - March 25 at 11:18 PMBuy Rating Affirmed for Astria Therapeutics on Promising STAR-0215 Data and Market Potentialmarkets.businessinsider.com - March 25 at 11:18 PMAstria Therapeutics' (ATXS) Buy Rating Reaffirmed at HC Wainwrightmarketbeat.com - March 25 at 1:10 PMAstria Therapeutics (NASDAQ:ATXS) Reaches New 12-Month High at $16.90marketbeat.com - March 25 at 11:15 AMAstria Therapeutics Reports Positive Initial Results From ALPHA-STAR Trial - Quick Factsmarkets.businessinsider.com - March 25 at 8:12 AMAstria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAEfinance.yahoo.com - March 25 at 8:12 AMAstria Therapeutics, Inc. (NASDAQ:ATXS) is favoured by institutional owners who hold 53% of the companyfinance.yahoo.com - March 23 at 6:20 PMAstria Therapeutics (NASDAQ:ATXS) Stock Price Down 6.9%marketbeat.com - March 20 at 12:46 PMAstria Therapeutics (NASDAQ:ATXS) Trading Up 3.8%marketbeat.com - March 19 at 11:58 AMAstria Therapeutics (NASDAQ:ATXS) Rating Reiterated by HC Wainwrightmarketbeat.com - March 18 at 4:33 PMAstria Therapeutics, Inc. (NASDAQ:ATXS) Sees Significant Decline in Short Interestmarketbeat.com - March 16 at 12:04 PMATXS Apr 2024 2.500 putfinance.yahoo.com - March 15 at 10:23 PMAstria Therapeutics (NASDAQ:ATXS) Hits New 52-Week High at $15.87marketbeat.com - March 15 at 12:38 PMWedbush Comments on Astria Therapeutics, Inc.'s FY2028 Earnings (NASDAQ:ATXS)marketbeat.com - March 6 at 8:33 AMAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - March 5 at 4:10 PMAnalysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL) and Astria Therapeutics (ATXS)markets.businessinsider.com - March 5 at 1:23 PMAnalysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Astria Therapeutics (ATXS)markets.businessinsider.com - March 5 at 1:23 PMAstria Therapeutics (NASDAQ:ATXS) Shares Gap Down Following Weak Earningsmarketbeat.com - March 5 at 10:51 AMAstria Therapeutics' (ATXS) Outperform Rating Reaffirmed at Wedbushmarketbeat.com - March 5 at 9:20 AMAstria Therapeutics (NASDAQ:ATXS) Posts Quarterly Earnings Results, Misses Expectations By $0.08 EPSmarketbeat.com - March 5 at 8:57 AMFmr LLC Sells 397,241 Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS)marketbeat.com - March 5 at 6:27 AMAstria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Updatebusinesswire.com - March 4 at 4:10 PMATXS Oct 2024 22.500 callfinance.yahoo.com - February 27 at 6:50 PMAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meetingfinance.yahoo.com - February 20 at 10:28 AMAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual Meetingbusinesswire.com - February 20 at 8:00 AMATXS Mar 2024 22.500 callfinance.yahoo.com - February 17 at 5:40 PMATXS Mar 2024 12.500 callfinance.yahoo.com - February 17 at 12:40 PMAstria Therapeutics, Inc. (NASDAQ:ATXS) Sees Large Growth in Short Interestmarketbeat.com - February 13 at 12:33 PMAstria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences Conferencefinance.yahoo.com - February 6 at 11:38 AMAstria Therapeutics (NASDAQ:ATXS) Shares Gap Up on Insider Buying Activitymarketbeat.com - February 6 at 10:42 AMInsider Buying: Astria Therapeutics, Inc. (NASDAQ:ATXS) Director Buys 2,481,350 Shares of Stockmarketbeat.com - February 5 at 6:38 PMAstria Therapeutics (NASDAQ:ATXS) Shares Gap Down to $13.10marketbeat.com - February 5 at 12:50 PMAstria Therapeutics Announces Offering to Fund Future Operationsmsn.com - February 1 at 8:16 PMChief Medical Officer Christopher Morabito Sells 10,000 Shares of Astria Therapeutics Incfinance.yahoo.com - January 30 at 10:03 PMAstria Therapeutics Announces Pricing of $125 Million Underwritten Offeringfinance.yahoo.com - January 30 at 5:03 PMAstria Therapeutics' (ATXS) "Outperform" Rating Reiterated at Wedbushmarketbeat.com - January 30 at 11:37 AMShort Interest in Astria Therapeutics, Inc. (NASDAQ:ATXS) Expands By 62.1%marketbeat.com - January 12 at 3:12 AMShort Interest in Astria Therapeutics, Inc. (NASDAQ:ATXS) Expands By 10.3%marketbeat.com - January 2 at 7:15 AMAstria Therapeutics, Inc. (NASDAQ:ATXS) Director Perceptive Advisors Llc Purchases 740,000 Sharesmarketbeat.com - December 22 at 3:24 PMAstria Therapeutics files $500M mixed securities shelfmsn.com - December 16 at 1:32 PMAstria Therapeutics, Inc. (NASDAQ:ATXS) Short Interest Up 23.0% in Novembermarketbeat.com - December 14 at 12:30 PM Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address “The Stock Market’s Bull Run is Far from Over” -Barrons (Ad)Barron's reports that the "stock market's bull run is FAR from over…" And recent economic growth will fuel the price of select stocks in the coming months! Click here for all the details now… ATXS Media Mentions By Week ATXS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ATXS News Sentiment▼0.610.61▲Average Medical News Sentiment ATXS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ATXS Articles This Week▼222▲ATXS Articles Average Week Get Astria Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ATXS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Arcturus Therapeutics News Today Innoviva News Today ABIVAX Société Anonyme News Today Pliant Therapeutics News Today Arcutis Biotherapeutics News Today ARS Pharmaceuticals News Today ORIC Pharmaceuticals News Today MacroGenics News Today Zentalis Pharmaceuticals News Today Tango Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ATXS) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceTop Project Outperforms BTC in 2023…Crypto 101 MediaForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisoryThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyFed launches fourth dollar overhaulStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astria Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.